BOUNDARIES IN SCIENCE POLICY MAKING

Abstract

We simultaneously explore the history of European Union policy on the commercialization of recombinant bovine growth hormone and the sociology of boundary drawing. We argue that, to understand why some boundary-drawing efforts succeed and others fail, we need to be attentive to the relatively stable discursive, organizational, and institutional factors that shape boundary construction. We suggest that attention to two discourses (scientism and social welfarism), the structure of policy making in the European Union, and the institutionalization of particular discourses in World Trade Organization regulations shed light on the E.U.-rbGH case.